4,201
Views
62
CrossRef citations to date
0
Altmetric
Original Article

Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba

, , , , , & show all
Pages 453-459 | Received 29 Apr 2010, Accepted 17 Sep 2010, Published online: 28 Oct 2010

References

  • Arbeeny, C.M. Addressing the unmet medical need for safe and effective weight loss therapies. Obes. Res. 2004, 12, 1191–1196.
  • Harrold, J., Williams, G., Wong, S. Neuroendocrine targets for the treatment of obesity: physiological roles and unrealized opportunities. Curr Med Chem 2003, 3, 141–155.
  • Wang, Y., Beydoun, M.A., Liang, L., Caballero, B., Kumanyika, S.K. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008, 16, 2323–2330.
  • Wang, Y., Beydoun, M.A. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol. Rev. 2007, 29, 6–28.
  • Hirani, V. Anthropometric measures, overweight and obesity. In: Sproston, K., Primatesta, P. (eds). Health Survey for England 2003. Volume 2: Risk Factors for Cardiovascular Disease. Joint Health Surveys Unit: London, 2004, pp. 143–179.
  • Cameron, A.J., Welborn, T.A., Zimmet, P.Z., Dunstan, D.W., Owen, N., Salmon, J., Dalton, M., Jolley, D., Shaw, J.E. Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med. J. Aust.s 2003, 178, 427–432.
  • Bogers, R.P., Bemelmans, W.J., Hoogenveen, R.T., Boshuizen, H.C., Woodward, M., Knekt, P., van Dam, R.M., Hu, F.B., Visscher, T.L., Menotti, A., Thorpe, R.J., Jr., Jamrozik, K., Calling, S., Strand,  B.H., Shipley, M.J.; for the BMI-CHD Collaboration Investigators. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch. Intern. Med. 2007, 167, 1720–1728.
  • National task force on the prevention and treatment of obesity. Overweight, obesity, and health risk. Arch. Intern. Med. 2000, 160, 898–904.
  • Hyde, R. Europe battles with obesity. Lancet 2008, 371, 2160–2161.
  • National Heart Lung and Blood Institute in cooperation with The National Institute of Diabetes and Digestive and Kidney Diseases. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. The evidence report, 1998.
  • Ballinger, A., Peikin, S.R. Orlistat: its current status as an anti-obesity drug. Eur. J. Pharmacol. 2002, 440, 109–117.
  • Yanovski, S.Z., Yanovski, J.A. Obesity. N. Engl. J. Med. 2002, 346, 591–602.
  • Winkler, F.K., D’Arcy, A., Hunziker, W. Structure of human pancreatic lipase. Nature 1990, 343, 771–774.
  • Tilbeurgh, H.V. Structure of the pancreatic lipase–procolipase complex. Nature 1992, 359, 159–162.
  • Gargouri, Y., Ransac, S., Verger, R. Covalent inhibition of digestive lipases: an in vitro study. Biochim. Biophys. Acta 1997, 1344, 6–37.
  • Hadváry, P., Lengsfeld, H., Wolfer, H. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem. J. 1988, 256, 357–361.
  • Drent, M.L., van der Veen, E.A. Lipase inhibition: a novel concept in the treatment of obesity. Int. J. Obes. Relat. Metab. Disord. 1993, 17, 241–244.
  • Bustanji, Y., Mohammad, M., Hudaib, M., Tawaha, K., Al-Masri, I., AlKhatib, H., Issa, A., Alali, F. Screening of some medicinal plants for their pancreatic lipase inhibitory potential. Jordan J. Pharm. Sci. 2010, Jordan J. Pharm. Sci. In Press.
  • Morikawa, T., Xie, Y., Asao, Y., Okamoto, M., Yamashita, C., Muraoka, O., Matsuda, H., Pongpiriyadacha, Y., Yuan, D., Yoshikawa, M. Oleanane-type triterpene oligoglycosides with pancreatic lipase inhibitory activity from the pericarps of Sapindus rarak. Phytochemistry 2009, 70, 1166–1172.
  • Nakai, M., Fukui, Y., Asami, S., Toyoda-Ono, Y., Iwashita, T., Shibata, H., Mitsunaga, T., Hashimoto, F., Kiso, Y. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J. Agric. Food Chem. 2005, 53, 4593–4598.
  • Tian, W.X., Li, L.C., Wu, X.D., Chen, C.C. Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase. Life Sci. 2004, 74, 2389–2399.
  • Cheng, J., Ni, H., Guo, W., Yu, L., Shen, Q., Lin, Y. Chinese medicinal composition effective in reducing blood glucose and blood lipid, and its preparation method and uses. Faming Zhuanli Shenqing Gongkai Shuomingshu 2007, CODEN: CNXXEV CN 101085121 A 20071212. Application: CN 2007-10024578 20070622.
  • Dubey, A.K., Devi, A., Kutty, G., Shankar, R.P. Hypolipidemic activity of Ginkgo biloba extract, EGB 761 in hypercholesterolemic wistar rats. Iran J. Pharmacol. Ther. 2005, 4, 9–12.
  • Christen, Y. Use of Ginkgo biloba extract for increasing muscle mass and reducing fat mass. Faming Zhuanli Shenqing Gongkai Shuomingshu 2005, CODEN: CNXXEV CN 1668321 A 20050914. Application: CN 2003-816570 20030715.
  • Duan, Z., Guo, S., He, D., Yan, X. Traditional Chinese medicine extract capable of inhibiting lipase activity. Faming Zhuanli Shenqing Gongkai Shuomingshu 2009, 24 pp. CODEN: CNXXEV CN 101361886 A 20090211 Application: CN 2007-10120014 20070807.
  • Mahady, G.B. Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature. J. Cardiovasc. Nurs. 2002, 16, 21–32.
  • Yao, P., Song, F., Li, K., Zhou, S., Liu, S., Sun, X., Nussler, A.K., Liu,  L. Ginkgo biloba extract prevents ethanol induced dyslipidemia. Am. J. Chin. Med. 2007, 35, 643–652.
  • Singh, B., Kaur, P., Gopichand, Singh, R.D., Ahuja, P.S. Biology and chemistry of Ginkgo biloba. Fitoterapia 2008, 79, 401–418.
  • Chen, J.W., Chen, Y.H., Lin, F.Y., Chen, Y.L., Lin, S.J. Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1559–1566.
  • Kudolo, G.B., Wang, W., Barrientos, J., Elrod, R., Blodgett, J. The ingestion of Ginkgo biloba extract (EGb 761) inhibits arachidonic acid-mediated platelet aggregation and thromboxane B2 production in healthy volunteers. J. Herb. Pharmacother. 2004, 4, 13–26.
  • Koltermann, A., Hartkorn, A., Koch, E., Fürst, R., Vollmar, A.M., Zahler, S. Ginkgo biloba extract EGb 761 increases endothelial nitric oxide production in vitro and in vivo. Cell. Mol. Life Sci. 2007, 64, 1715–1722.
  • Yao, Z.X., Han, Z., Drieu, K., Papadopoulos, V. Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels. J. Nutr. Biochem. 2004, 15, 749–756.
  • Maitra, I., Marcocci, L., Droy-Lefaix, M.T., Packer, L. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem. Pharmacol. 1995, 49, 1649–1655.
  • Cho, H.J., Nam, K.S. Inhibitory effect of ginkgolide B on platelet aggregation in a cAMP- and cGMP-dependent manner by activated MMP-9. J. Biochem. Mol. Biol. 2007, 40, 678–683.
  • OMEGA (version 2.3.2) 2008. OpenEye Scientific Software Inc., Santa Fe, New Mexico, USA.
  • FRED (version 2.2.5) 2009. OpenEye Scientific Software, (www.eyesopen.com), USA.
  • Egloff, M.P., Marguet, F., Buono, G., Verger, R., Cambillau, C., van Tilbeurgh, H. The 2.46 A resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate. Biochemistry 1995, 34, 2751–2762.
  • Lee, Y.P., Chung, G.H., Rhee, J.S. Purification and characterization of Pseudomonas fluorescens SIK W1 lipase expressed in Escherichia coli. Biochim. Biophys. Acta, Lipids Lipid Metab. 1993, 1169, 156–164.
  • Sharma, N., Sharma, V.K., Seo, S.Y. Screening of some medicinal plants for anti-lipase activity. J. Ethnopharmacol. 2005, 97, 453–456.
  • Mohammad, M., Aiedeh, K.M., Alkhatib, H.S., Tawaha,  K., Alkhalidi,  B., Al-Masri, I.M., Hamed, S., Bustanji, Y.A. Comparative enzymatic inhibition assay as a surrogate indicator of pharmaceutical and potency equivalence of two orlistat formulations. Jordan J. Pharm. Sci. 2010, 3, 69–75.
  • Ding, Z. Studies on extraction and isolation of flavonoids from ginkgo leaves. J. Food Quality 1999, 22, 693–700.
  • Bustanji, Y., Taha, M.O., Almasri, I.M., Al-Ghussein, M.A., Mohammad, M.K., Alkhatib, H.S. Inhibition of glycogen synthase kinase by curcumin: investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation. J. Enzyme Inhib. Med. Chem. 2009, 24, 771–778.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.